Pearls & Perspectives: Adapting to Innovation Across a Career in Urology, with Alan J. Wein, MD, PhD (hon), FACS

Welcome back to Pearls & Perspectives!

In this episode of Pearls and Perspectives, host Amy Pearlman, MD, sits down with longtime mentor and former Chief of the Division of Urology at the University of Pennsylvania, Alan J. Wein, MD, PhD (hon), FACS, at the Urology on the Beach conference in Miami, Florida. Wein now serves as a professor of urology at the Desai Sethi Urology Institute at the University of Miami.

Reflecting on a career that has spanned more than 5 decades—from medical school and residency training in the 1960s through academic leadership and clinical practice into the modern era—Wein offers listeners a rare perspective on how the field of urology has evolved, and how clinicians can thoughtfully evolve alongside it.

Throughout the conversation, Wein explores the rapid expansion of treatment options for benign prostatic hyperplasia and lower urinary tract dysfunction, noting that while innovation has broadened the therapeutic landscape, it has also introduced new complexity into clinical decision-making. Drawing from his own transition away from open surgical approaches and toward collaborative models of care in the robotic era, he discusses the importance of recognizing when to adopt emerging technologies, and when it may be more appropriate to refer patients to trusted colleagues with specialized expertise. The discussion highlights how leadership roles within academic departments may shape these decisions differently than those made in private or community-based practice, particularly when balancing patient outcomes, resident education, and subspecialty coverage.

Wein also addresses the growing role of peer-to-peer dialogue in evaluating new therapies, emphasizing that real-world insights from respected colleagues can often provide critical context that may not be apparent in published outcomes alone. Using examples ranging from intradetrusor onabotulinumtoxinA injection to sacral neuromodulation and ambulatory urodynamic monitoring, he underscores the need for clinicians to critically appraise both the literature and their own clinical experience, particularly in an era where selective reporting may obscure meaningful patient-centered end points.

Finally, the episode revisits a foundational clinical principle that continues to inform modern practice: diagnostic testing is only valuable when it reproduces and correlates with the patient’s reported symptoms. In the context of urodynamic evaluation, Wein explains how failure to replicate real-world complaints during testing may limit the utility of even technically sound studies, reinforcing the importance of individualized clinical interpretation. As the field moves toward more physiologic and minimally invasive diagnostic approaches, such as ambulatory monitoring systems, listeners are encouraged to consider how evolving technologies may better capture the lived experiences that ultimately guide therapeutic decision-making.